State Street SPDR S&P Biotech ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
157.03
-0.65 (-0.41%)
Oct 1, 2026, 11:17 AM EDT - Market open
XBI Holdings Information
XBI is an equity ETF with a total of 167 individual holdings. The top holdings are Moderna stock at 2.17%, Twist Bioscience at 2.14%, Natera at 1.81%, Iovance Biotherapeutics at 1.59%, and Amgen at 1.56%.
Total Holdings
167
Top 10 Percentage
16.83%
Asset Class
Equity
ETF Category
Health
Assets
10.19B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 2.17% |
| 2 | TWST | Twist Bioscience Corporation | 2.14% |
| 3 | NTRA | Natera, Inc. | 1.81% |
| 4 | IOVA | Iovance Biotherapeutics, Inc. | 1.59% |
| 5 | AMGN | Amgen Inc. | 1.56% |
| 6 | BIIB | Biogen Inc. | 1.56% |
| 7 | ABBV | AbbVie Inc. | 1.52% |
| 8 | HALO | Halozyme Therapeutics, Inc. | 1.50% |
| 9 | GILD | Gilead Sciences, Inc. | 1.50% |
| 10 | CRSP | CRISPR Therapeutics AG | 1.49% |
| 11 | TGTX | TG Therapeutics, Inc. | 1.48% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 1.46% |
| 13 | EXEL | Exelixis, Inc. | 1.45% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.42% |
| 15 | RVMD | Revolution Medicines, Inc. | 1.42% |
| 16 | INCY | Incyte Corporation | 1.41% |
| 17 | SYRE | Spyre Therapeutics, Inc. | 1.41% |
| 18 | PTGX | Protagonist Therapeutics, Inc. | 1.40% |
| 19 | KRYS | Krystal Biotech, Inc. | 1.39% |
| 20 | PTCT | PTC Therapeutics, Inc. | 1.39% |
| 21 | UTHR | United Therapeutics Corporation | 1.37% |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.35% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.34% |
| 24 | REGN | Regeneron Pharmaceuticals, Inc. | 1.34% |
| 25 | TVTX | Travere Therapeutics, Inc. | 1.31% |
As of Sep 29, 2026